Asia/Oceania
Gene Solutions, NEWCL Establish NGS Lab in Taiwan
The companies aim to jointly commercialize Gene Solutions' suite of prenatal and cancer tests throughout Taiwan.
MiRxes Launches HK$880.5M IPO on Hong Kong Stock Exchange
The Singaporean company said it will use the proceeds to support commercialization of its gastric cancer test, further assay development, and other business purposes.
Digital Pathology Software Developer Medmain Raises $3.3M
The money will support the development of the firm's PidPort system for storage, viewing, sharing, and analysis of digital images of pathology slides.
Top Five Articles on 360Dx Last Week: Mursla Bio's Liver Cancer Test; Use of LDTs Under IVDR; More
Last week, readers were most interested in a story about Mursla's liver cancer test for detecting microRNA and protein targets within extracellular vesicles.
Promega Microsatellite Instability Detection Kit Garners China NMPA Approval
The ProDx MSI Detection Kit is now available for clinical testing in China to screen for colorectal cancer patients who may benefit from additional Lynch syndrome testing.